Correction: Ivermectin Prophylaxis Used for COVID-19: A Citywide, Prospective, Observational Study of 223,128 Subjects Using Propensity Score Matching

Cureus. 2022 Mar 24;14(3):c61. doi: 10.7759/cureus.c61. eCollection 2022 Mar.

¹ Medicine, Instituto Kerr, São Paulo, BRA.
² Clinical Endocrinology, Corpometria Institute, Brasilia, BRA.
³ Clinical Endocrinology, Applied Biology Inc, Irvine, USA.
⁴ Animal Sciences, Universidade Estadual de São Paulo (UNESP), São Paulo, BRA.
⁵ Genetics, Universidade de São Paulo, Ribeirão Preto, BRA.
⁶ Genetics, Centro Técnico de Avaliação Genômica - C.T.A.G., Ribeirão Preto, BRA.
⁷ Bioinformatics, Itajaí City Hall, Itajaí, BRA.
⁸ Internal Medicine, Front Line COVID-19 Critical Care Alliance (FLCCC), Madison, USA.
⁹ Dentistry, University of Toronto, Toronto, CAN.
¹⁰ Data Analysis, Universidad EAFIT, Medellín, COL.

Abstract

[This corrects the article DOI: 10.7759/cureus.21272.].